Important contributions
- Kadri N, Korpos E, Gupta S, Briet C, Löfbom L, Yagita H, Lehuen A, Boitard C, Holmberg D, Sorokin L, Cardell SL. CD4+ Type II NKT Cells Mediate ICOS and Programmed Death-1–Dependent Regulation of Type 1 Diabetes. J Immunol 1101390; published ahead of print February 27, 2012.
- Wermeling F, Lind SM, Jordö ED, Cardell SL, Karlsson MC. 2010. Invariant NKT cells limit activation of autoreactive CD1d positive B cells. J Exp Med. 207(5):943-52.
- Blomqvist, M., Rhost, S., Teneberg, S., Löfbom, L., Osterbye, T., Brigl, M., Månsson, J.-E., and Cardell, S. L. 2009. Multiple tissue specific isoforms of sulfatide activate CD1drestricted type II NKT cells. Eur J Immunol. 39:1726-1735.
- Rolf, J. Berntman, E., Stenström, M., Smith, E., Månsson, R., Stenstad, H., Yamagata, T., Agace, W., Sigvardsson, M., and Cardell, S. L. 2008. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets. Mol. Immunol. 45:2607-2620.
- Berntman, E., Rolf, J., Johansson, C., Anderson, P., and Cardell, S. L. 2005. The role of CD1d restricted natural killer T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur. J. Immunol. 35:2100-2109.
- Duarte, N., Stenström, M., Campino, S., Bergman, M.-L., Holmberg, D. and Cardell, S. 2004. Prevention of diabetes in non obese diabetic (NOD) mice by CD1d-restricted nonclassical NKT cells. J. Immunol. 173:3112-3118.
- Sköld, M., Faizunnessa, N. N., C.-R. Wang and Cardell, S. 2000. CD1d-specific NK1.1+ T cells with a transgenic variant T cell receptor. J. Immunol. 165:168.
- Cardell, S., Tangri, S. Chan, S., Kronenberg, M., Benoist, C. and Mathis, D. 1995. CD1-restricted CD4+ T cells in MHC class II-deficient mice. J. Exp. Med. 182:993.
Find the complete list of publications here